Regulatory News

January 25, 2018 / 10:04 PM / 3 months ago

BRIEF-Anthera Receives Positive Nasdaq Listing Determination

Reuters Staff

1 Min Read

Jan 25 (Reuters) - Anthera Pharmaceuticals Inc:

* ANTHERA RECEIVES POSITIVE NASDAQ LISTING DETERMINATION Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.